A Multi-Center Study To Evaluate Multiple Doses of NT100 Following IVF In Women With Repeated IVF Failures (Thrive-IVF)

Completed · Phase 2 · Has a placebo group

Conditions studied: Repeated IVF Failure

In brief

The purpose of this study is to evaluate the efficacy, safety and tolerability of multiple doses of subcutaneous NT100 vs placebo following in vitro fertilization (IVF) in women with a history of repeated IVF failures.

Key facts

Study ID
NCT01864356
Run by
Nora Therapeutics, Inc.
People needed
157
Starts
2013-05-01
Expected to finish
2014-09-01
Last updated by the study team
2014-11-20

Who can join

Age: 21 and older, up to 38. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.